Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Williams, David
Item TypeName
Academic Article Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.
Academic Article Somatic gene therapy. Current status and future prospects.
Academic Article Gene therapy of somatic cells: status and prospects.
Academic Article Gaining the hard yard: pre-clinical evaluation of lentiviral-mediated gene therapy for the treatment of beta-thalassemia.
Academic Article An international conversation on Stem Cell Gene Therapy. 4th Stem Cell Conference on Stem Cell Gene Therapy, Thessaloniki, Greece, 13-17 September 2007.
Academic Article Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases.
Academic Article Medicine. Gene therapy--new challenges ahead.
Academic Article Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome.
Grant ADHESION AND STEM CELL SURVIVAL AND ENGRAFTMENT
Grant Novel Molecular and Cellular Therapies in Fanconi Anemia
Grant Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
Grant Pathophysiology of Human Blood Cells
Grant Chemoresistance and Stem Cell Selection
Grant Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
Grant CORE CENTERS OF EXCELLENCE IN MOLECULAR HEMATOLOGY
Grant Disseminating Curative Biological Therapies for Rare Pediatric Diseases
Academic Article Gene Therapy 2000.
Grant Employing novel humanized murine strains to develop hematopoietic stem cell gene therapeutic approaches for very early-onset inflammatory bowel disease due to IL10-receptor deficiency.
Grant Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
Academic Article Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
Academic Article Gene Therapy for Cerebral Adrenoleukodystrophy.
Academic Article NIH recombinant DNA Advisory Committee continues to ponder adverse event associated with AAV gene therapy trial.
Academic Article Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.
Academic Article NIH funding of gene therapy trials.
Academic Article A "vector drain" in US gene therapy development?
Academic Article Two Decades of Molecular Therapy and a 35-Year Personal View of Changes in Gene Therapy.
Academic Article Evolving Gene Therapy in Primary Immunodeficiency.
Academic Article Gene therapy advances but struggles to interpret safety data in small animal models.
Academic Article ESCGT 2008: progress in clinical gene therapy.
Academic Article Gene therapy continues to mature and to face challenges.
Academic Article ASGT advises NIH on funding of gene therapy trials.
Academic Article New AAV serotypes may broaden the therapeutic pipeline to human gene therapy.
Academic Article Transatlantic consortium spotlights need for changes in gene therapy trials.
Grant Boston Consortium to Cure SCD - Williams/Ellen Grant
Grant Boston Consortium to Cure SCD - Williams/John Higgins
Academic Article Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy.
Grant Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
Search Criteria
  • Gene Therapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.